March 26, 2020: Lopinavir/ritonavir falls short against COVID-19; impact of PrEP scale-up on HIV diagnoses; long-term cost-effectiveness of various HIV interventions; disparities in virologic suppression among young people.
With Truvada going generic soon in the U.S., public health officials will need to make some decisions to make access to both drugs sustainable.
Feb. 13, 2020: PrEP's psychosocial benefits; supplementing ADAP with Obamacare plans; lack of HIV and HCV testing for people who inject drugs; frailty is more common, but not more deadly, in HIV settings.
Barebacking is not just an act. It’s a stand-in for so many of our feelings about queer sexuality.
Thanks to decades of extensive scientific research, we now have extremely reliable ways to prevent HIV transmission. Here’s a breakdown of the tools you can use to prevent HIV.
Teaching young people of all ages about HIV is essential. But how do you start to outline a class?
Sex and intimacy can be a challenge if your HIV-negative partner is still afraid of you.
IPERGAY scientists recommended that clinicians screen patients who request PrEP, as well as patients who are already using it, for a number of key HCV risk factors.
Oral Arguments in Antitrust Case Against HIV Drug Companies Began Last Week. Plaintiff Peter Staley Explains the Case
The case could change the way pharma companies make agreements to keep generic versions of single-tablet pills at bay.
Many fear the push to put more people on the new brand-name drug before Truvada goes generic this year.